Combination Drug Therapy Shows Promise for a Treatment-Resistant Cancer

A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs), according to a laboratory study led by research

Related Keywords

Massachusetts ,United States ,Kai Pollard ,Lindy Zhang ,Christine Pratilas ,Johns Hopkins ,Jiawan Wang ,Nicolas Llosa ,Novartis Institutes For Biomedical Research In Cambridge ,Neurofibromatosis Therapeutic Acceleration Program ,Novartis ,Nf Research Initiative ,Children Cancer Foundation ,Department Of Biomedical Engineering ,Johns Hopkins University ,Novartis Institutes For Biomedical Research ,Masonic Cancer Center ,Genentech ,Johns Hopkins Kimmel Cancer Center ,University Of Minnesota ,Pacific Northwest National Laboratory In Seattle ,Johns Hopkins Kimmel Cancer ,Ana Calizo ,Pacific Northwest National Laboratory ,Siteman Cancer Center ,Washington University ,Biomedical Engineering ,Novartis Institutes ,Biomedical Research ,Hyundai Hope ,Cancer Foundation ,Kura Oncology ,Day One Biopharmaceuticals ,Newswise ,Alignant Peripheral Nerve Sheath Tumors Johns Hopkins Kimmel Cancer Center Christine Pratilas ,All Journal News ,Grant Funded News ,Dancer ,Healthcare ,Johns Hopkins Medicine ,